LifeStance Therapists & Psychiatrists Carmel
11900 North Pennsylvania Street, Suite 104, Carmel
4.7(120 Google reviews)
United States
6 listed treatment centers serving Carmel and the surrounding area.
11900 North Pennsylvania Street, Suite 104, Carmel
4.7(120 Google reviews)
14555 Hazel Dell Parkway, 140, Carmel
5.0(19 Google reviews)
11495 North Pennsylvania Street, Ste. 100, Carmel
4.3(9 Google reviews)
For Carmel residents, the cost of Spravato depends on insurance benefits, the treatment setting, and the services billed. Both the medication and the visit for administration and observed monitoring may generate charges. Ask for an estimate that includes all parts of treatment, rather than only the nasal spray.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials before deciding whether to authorize care. Ask your prescribing clinician to help gather medication names, doses, treatment dates, and notes about response or side effects. Find out who submits the paperwork, whether anything is missing, and whether authorization must be renewed during treatment. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Indiana Medicaid coverage also depends on the applicable program, plan, and setting. Confirm benefits with both the insurer and the treatment center; do not assume that accepting insurance means every service is covered.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which charges, if any, a program helps with.
Before starting, ask:
This directory currently has no listed treatment center in Carmel. The available information also provides no other Indiana cities with listed centers to suggest nearby. That is a directory limitation, not proof that treatment is unavailable. Ask your prescribing clinician or insurer to help identify a setting, then confirm directly that it is certified through the Spravato REMS program before scheduling.
Spravato cannot be taken home. You self-administer the nasal spray in a REMS-certified healthcare setting under direct observation of a healthcare provider. Monitoring continues for at least two hours after each dose, and the full appointment may take longer for preparation and assessment before you leave. Ask the center how much time to reserve.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the appropriate schedule; do not assume that visits will become less frequent on a fixed date.
Arrange for someone else to drive you home after every session. You must not drive or operate machinery until the next day after a restful sleep. Confirm the center's pickup requirements, coordinate with a trusted driver, and make a backup plan if that person becomes unavailable.
When planning time off work, allow for travel, the full appointment, and recovery afterward. Consider childcare and other responsibilities, too. If work involves driving or machinery, discuss scheduling around the driving restriction rather than planning to return immediately after treatment.
This directory currently has no listed center in Carmel and no other Indiana cities with listed centers to recommend. Ask your clinician or insurer for help locating a treatment setting. Before booking, confirm directly that the setting is REMS-certified, is accepting patients, and can evaluate you for treatment. A statement that a location offers Spravato is not, by itself, confirmation of certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your diagnosis, treatment history, health conditions, and medications to decide whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask your insurer about coverage for both the medication and the monitored visit, network requirements, and your share of costs. Medicare and Indiana Medicaid may cover treatment depending on the plan and setting, but coverage and center participation must be confirmed individually.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. You cannot take the medication home. Arrange a driver afterward, and do not drive or operate machinery until the next day after a restful sleep.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history, all medications, and any substance-use concerns so your clinician can assess risks and explain monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when that is clinically needed. Do not wait for a treatment appointment if you need urgent help. Call or text 988 for crisis support. If there is immediate danger or a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.